Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes

[1]  N. Calcutt,et al.  The pathological interaction between diabetes and presymptomatic Alzheimer's disease , 2009, Neurobiology of Aging.

[2]  H. Soininen,et al.  β‐Amyloid deposition in brains of subjects with diabetes , 2009, Neuropathology and applied neurobiology.

[3]  V. Hachinski,et al.  Vascular risk factors and Alzheimer’s disease , 2008, Expert review of neurotherapeutics.

[4]  D. Bennett,et al.  Diabetes is related to cerebral infarction but not to AD pathology in older persons , 2006, Neurology.

[5]  Tetsuaki Arai,et al.  LRRK2 Expression in Normal and Pathologic Human Brain and in Human Cell Lines , 2006, Journal of neuropathology and experimental neurology.

[6]  M. Folstein,et al.  Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: review and hypothesis , 2006, Neurobiology of Aging.

[7]  R. Martins,et al.  Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes , 2006, Neurobiology of Aging.

[8]  P. Scheltens,et al.  Risk of dementia in diabetes mellitus: a systematic review , 2006, The Lancet Neurology.

[9]  B. Winblad,et al.  Diabetes mellitus and risk of dementia in the Kungsholmen project , 2004, Neurology.

[10]  M. Sogayar,et al.  Amyloidogenicity and Cytotoxicity of Recombinant Mature Human Islet Amyloid Polypeptide (rhIAPP)* , 2004, Journal of Biological Chemistry.

[11]  Per Westermark,et al.  Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.

[12]  M. Ristow,et al.  Neurodegenerative disorders associated with diabetes mellitus , 2004, Journal of Molecular Medicine.

[13]  D. Bennett,et al.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. , 2004, Archives of neurology.

[14]  Ronald C Petersen,et al.  Increased risk of type 2 diabetes in Alzheimer disease. , 2004, Diabetes.

[15]  J. Haefliger,et al.  Critical Role of the Transcriptional Repressor Neuron-restrictive Silencer Factor in the Specific Control of Connexin36 in Insulin-producing Cell Lines* , 2003, Journal of Biological Chemistry.

[16]  H. Grossman.  Does Diabetes Protect or Provoke Alzheimer's Disease? Insights Into the Pathobiology and Future Treatment of Alzheimer's Disease , 2003, CNS Spectrums.

[17]  B. Vellas,et al.  Facteurs de risque vasculaire et maladie d'Alzheimer. , 2003 .

[18]  Leslie Wilson,et al.  Differential regulation of microtubule dynamics by three- and four-repeat tau: Implications for the onset of neurodegenerative disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Milam,et al.  Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. , 2003, Molecular vision.

[20]  Xudong Huang,et al.  Cytosolic β-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease , 2003, The Lancet.

[21]  Jaime Caro,et al.  Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000. , 2003, Clinical therapeutics.

[22]  P. Boutin,et al.  Islet-brain1/C-Jun N-terminal kinase interacting protein-1 (IB1/JIP-1) promoter variant is associated with Alzheimer's disease , 2003, Molecular Psychiatry.

[23]  P. Boutin,et al.  Islet-brain 1/c-Jun N-terminal kinase interacting protein-1 (IB1/JIP-1) promoter variant is associated with Alzheimer's disease , 2003, Molecular Psychiatry.

[24]  W. Engel,et al.  Newest pathogenetic considerations in inclusion-body myositis: Possible role amyloid-β, cholesterol, relation to aging and to alzheimer’s disease , 2002, Current rheumatology reports.

[25]  L. Launer,et al.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.

[26]  P. Mcgeer,et al.  High stability of mRNAs postmortem and protocols for their assessment by RT-PCR. , 2001, Brain research. Brain research protocols.

[27]  Lars Bertram,et al.  New Frontiers in Alzheimer's Disease Genetics , 2001, Neuron.

[28]  A. Myers,et al.  The genetics of late-onset Alzheimer's disease , 2001, Current opinion in neurology.

[29]  J. Manson,et al.  Type 2 diabetes and cognitive function in community-dwelling elderly women. , 2001, Diabetes care.

[30]  P. O'Connell,et al.  A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans. , 2001, American journal of human genetics.

[31]  M G McInnis,et al.  Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. , 2000, Science.

[32]  P. Amouyel,et al.  Interactions between Apolipoprotein E and Apolipoprotein(a) in Patients with Late-Onset Alzheimer Disease , 2000, Annals of Internal Medicine.

[33]  C. Dina,et al.  The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes , 2000, Nature Genetics.

[34]  E. Welker,et al.  Spatial, temporal and subcellular localization of islet‐brain 1 (IB1), a homologue of JIP‐1, in mouse brain , 2000, The European journal of neuroscience.

[35]  A Hofman,et al.  Diabetes mellitus and the risk of dementia , 1999, Neurology.

[36]  R. Stewart,et al.  Vascular Risk Factors and Alzheimer's Disease , 1999, The Australian and New Zealand journal of psychiatry.

[37]  A. Thapar,et al.  Thapar and Barrett reply , 1999, Molecular Psychiatry.

[38]  R. Kraftsik,et al.  Alzheimer disease: curly fibers and tangles in organs other than brain. , 1999, Journal of neuropathology and experimental neurology.

[39]  R. Kraftsik,et al.  Curly fiber and tangle-like inclusions in the ependyma and choroid plexus--a pathogenetic relationship with the cortical Alzheimer-type changes? , 1998, Journal of neuropathology and experimental neurology.

[40]  Johanna Kuusisto,et al.  Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study , 1997, BMJ.

[41]  P. O'Brien,et al.  Risk of dementia among persons with diabetes mellitus: a population-based cohort study. , 1997, American journal of epidemiology.

[42]  R. Motter,et al.  Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[43]  W. Halliday,et al.  In situ characterization of beta-amyloid in Alzheimer's diseased tissue by synchrotron Fourier transform infrared microspectroscopy. , 1996, Biophysical journal.

[44]  M. Esiri,et al.  APOLIPOPROTEIN E IS ASSOCIATED WITH ISLET AMYLOID AND OTHER AMYLOIDOSES: IMPLICATIONS FOR ALZHEIMER'S DISEASE , 1996, The Journal of pathology.

[45]  M. Koschinsky,et al.  Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). , 1995, Clinical chemistry.

[46]  D. Selkoe,et al.  Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau. , 1994, The American journal of pathology.

[47]  Thomas Wisniewski,et al.  Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid , 1992, Neuroscience Letters.

[48]  C B Wollheim,et al.  Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. , 1992, Endocrinology.

[49]  R. A. Crowther,et al.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease , 1989, Neuron.

[50]  D. Selkoe,et al.  Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. , 1989, Nature.

[51]  D. Steiner,et al.  An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing. , 1988, The Journal of biological chemistry.

[52]  J. Rothbard,et al.  Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[53]  R. Turner,et al.  Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Rothbard,et al.  DIABETES-ASSOCIATED PEPTIDE , 1987, The Lancet.

[55]  D. W. Hayden,et al.  Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. , 1987, The American journal of pathology.

[56]  Steel Cm.  DNA in medicine. The tools. Part II. , 1984 .